Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study

被引:228
作者
Dessein, PH
Shipton, EA
Stanwix, AE
Joffe, BI
Ramokgadi, J
机构
[1] Univ Witwatersrand, CH Baragwanath Hosp, Pain Relief & Res Unit, Johannesburg, South Africa
[2] Univ Witwatersrand, Milpark Hosp, Rheumatol Unit, Johannesburg, South Africa
[3] Univ Witwatersrand, Johannesburg Hosp, Dept Rheumatol, Johannesburg, South Africa
[4] Johannesburg Hosp, Carbohydrate & Lipid Metab Res Unit, Johannesburg, South Africa
[5] UNISA, Dept Quantitat Management, Pretoria, South Africa
关键词
D O I
10.1136/ard.59.7.539
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives-Insulin resistance (IR) has been increasingly implicated in the pathogenesis of gout. The lipoprotein abnormalities described in hyperuricaemic subjects are similar to those associated with IR, and insulin influences renal urate excretion. In this study it was investigated whether dietary measures, reported to be beneficial in IR, have serum uric acid (SU) and lipid lowering effects in gout. Methods-Thirteen non-diabetic men (median age 50, range 38-62) were enrolled. Each patient had had at least two gouty attacks during the four months before enrolment, Dietary recommendations consisted of calorie restriction to 6690 kJ (1600 kcal) a day with 40% derived from carbohydrate, 30% from protein, and 30% from fat; replacement of refined carbohydrates with complex ones and saturated fats with mono- and polyunsaturated ones. At onset and after 16 weeks, fasting blood samples were taken for determination of SU, serum cholesterol (C), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and triglycerides (TGs). Results were expressed as median (SD). Results- At onset, the body mass index (BMI) was 30.5 (8.1) kg/m(2). Dietary measures resulted in weight loss of 7.7 (5.4) kg (p = 0.002) and a decrease in the frequency of monthly attacks from 2.1 (0.8) to 0.6 (0.7) (p = 0.002). The SU decreased from 0.57 (0.10) to 0.47 (0.09) mmol/l (p = 0.001) and normalised in 7 (58%) of the 12 patients with an initially raised level. Serum cholesterol decreased from 6.0 (1.7) to 4.7 (0.9) mmol/l (p = 0.002), LDL-C from 3.5 (1.2) to 2.7 (0.8) mmol/l (p = 0.004), TGs from 4.7 (4.2) to 1.9 (1.0) mmol/l (p = 0.001), and C:HDL-C ratios from 6.7 (1.7) to 5.2 (1.0) (p = 0.002). HDL-C levels increased insignificantly. High baseline SU, frequency of attacks, total cholesterol, LDL-C and TC levels, and total C:HDL-C ratios correlated with higher decreases in the respective variables upon dietary intervention (p < 0.05). Conclusion-The results suggest that weight reduction associated with a change in proportional macronutrient intake, as recently recommended in IR, is beneficial, reducing the SU levels and dyslipidaemia in gout. Current dietary recommendations for gout may need re-evaluation.
引用
收藏
页码:539 / 543
页数:5
相关论文
共 29 条
  • [1] [Anonymous], 1995, Enter the Zone
  • [2] Assmann G, 1998, EUR HEART J, V19, pA2
  • [3] INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY
    CASTELLI, WP
    GARRISON, RJ
    WILSON, PWF
    ABBOTT, RD
    KALOUSDIAN, S
    KANNEL, WB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20): : 2835 - 2838
  • [4] CIGOLINI M, 1995, INT J OBESITY, V19, P92
  • [5] COHEN MG, 1998, RHEUMATOLOGY, V8, P1
  • [6] CLINICAL IMPLICATIONS OF INSULIN-RESISTANCE SYNDROMES
    DAVIDSON, MB
    [J]. AMERICAN JOURNAL OF MEDICINE, 1995, 99 (04) : 420 - 426
  • [7] MEDITERRANEAN ALPHA-LINOLENIC ACID-RICH DIET IN SECONDARY PREVENTION OF CORONARY HEART-DISEASE
    DELORGERIL, M
    RENAUD, S
    MAMELLE, N
    SALEN, P
    MARTIN, JL
    MONJAUD, I
    GUIDOLLET, J
    TOUBOUL, P
    DELAYE, J
    [J]. LANCET, 1994, 343 (8911) : 1454 - 1459
  • [8] DESSEIN PH, 1999, AFR LEAG RHEUM AFLAR
  • [9] Hyperlipidaemia in hyperuricaemia and gout
    Emmerson, B
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1998, 57 (09) : 509 - 510
  • [10] Drug therapy - The management of gout
    Emmerson, BT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (07) : 445 - 451